Abiomed Inc logo

Abiomed Inc Investor Relations Material

Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It provides Impella 2.5 system, a percutaneous micro heart pump with integrated motor and sensors for use by interventional cardiologists to treat patients in cardiogenic shock; Impella CP system which enables physicians to treat patients needing circulatory support; Impella 5.0 system that provides left ventricular support; and Impella LD heart pump for use in high risk percutaneous coronary interventions

Latest company events

Ticker symbol



United States of America

About the company


Dig deeper into the Abiomed Inc fundamentals on Quartr.

  • Skip straight to the Q&A session
  • Receive notifications about new events
  • Connect the financial calender on your phone
  • Figure out why the stock is up or down
  • Read the transcripts or scroll the deck
  • Access earnings or press releases
App store link
Android play link
Quartr app screenshot